GleanMark

RETAVASE Trademark

RETAVASE is a USPTO trademark filed by EKR THERAPEUTICS, INC.. Status: Cancelled.

Trademark Facts

MarkRETAVASE
Serial Number75324869
Registration Number2175074
StatusCancelled
Filing Date1997-07-15
Registration Date1998-07-21
Mark TypeWord
Nice Classes005 (Pharmaceuticals)
OwnerEKR THERAPEUTICS, INC.
Attorney of RecordJonathan Williams
Prosecution Events25
Latest EventC8.T on 2019-04-23

Goods & Services

cardiovascular agent, namely, a recombinant plasminogen activator compound, for use in the management of acute myocardial infarction

Related